Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Poziotinib for Patients With HER2 Exon 20 Mutant Non-Small-Cell Lung Cancer: Results From a Phase II TrialJ. Clin. Oncol 2021 Sep 22;[EPub Ahead of Print], YY Elamin, JP Robichaux, BW Carter, M Altan, DL Gibbons, FV Fossella, VK Lam, AB Patel, MV Negrao, X Le, FE Mott, J Zhang, L Feng, G Blumenschein, AS Tsao, JV Heymach
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.